The partners enter a three-year agreement to deploy AI agents via Owkin's K Pro platform to accelerate research, competitive ...
Adaption's new AutoScientist tool is designed to let models adapt to specific capabilities quickly through an automated ...
On May 6, 2026, the Food and Drug Administration (“FDA” or “the Agency”) issued a press release officially announcing a pilot program for ...
Fangzhou Inc. ('Fangzhou” or the 'Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and ...
Bengaluru and Delaware-based LiteFold is a biotech AI-native platform designed to accelerate computational biology workflows.
In drug discovery, a failed sample run is not just a setback - it can mean months of lost work and significant cost. At ...
Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how ...
Artrya’s FDA-cleared AI heart imaging tools are now reimbursable in the US, targeting one of healthcare’s deadliest blind ...
Agentic AI that can plan and execute complex scientific work using natural language, configure the platform itself, and ...
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
It’s not just you. Most companies aren’t seeing a return on AI investment. But here are ways to change that.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results